Neuropeptides
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.7 | Q3 | 40.5% | 0.786 | Q2 | 76.7% |
| 2024 | 2.7 | Q3 | 44.9% | 0.637 | Q2 | 70.4% |
| 2023 | 2.5 | Q3 | 36.1% | 0.716 | Q2 | 76.4% |
| 2022 | 2.9 | Q3 | 34.7% | 0.719 | Q2 | 77.5% |
| 2021 | 3.2 | Q3 | 36.5% | 0.726 | Q2 | 78.5% |
| 2020 | — | — | 0.830 | Q2 | 80.7% | |
| 2019 | — | — | 0.814 | Q2 | 80.8% | |
| 2018 | — | — | 0.818 | Q2 | 79.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0143-4179
ISSN
1532-2785
country
GBcoverage
1980-2026